| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |